Protective effect of glutathione against liver warm ischemia-reperfusion injury in rats is associated with regulation of P-selectin and neutrophil infiltration

Anatomical Record

Volumn 291, Issue 8, 2008, Pages 1016-1022

  Xue, Fei ^a   Wang, Guangtian ^b   Pang, Zhigang ^b   Liu, Chao ^b   Liang, Tingbo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Glutathione; Ischemia reperfusion injury; Liver; P selectin

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; PADGEM PROTEIN;

ANIMAL; ARTICLE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC PRECONDITIONING; LIVER; LIVER CIRCULATION; METABOLISM; METHODOLOGY; NEUTROPHIL; PHYSIOLOGY; PORTAL VEIN; RAT; REPERFUSION INJURY;

ANIMALS; GLUTATHIONE; INJECTIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING; LIVER; LIVER CIRCULATION; MALONDIALDEHYDE; NEUTROPHILS; P-SELECTIN; PORTAL VEIN; RATS; REPERFUSION INJURY;

EID: 52049085577     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20725     Document Type: Article

References (30)

1. Beauharnois ME, Lindquist KC, Marathe D, Vanderslice P, Xia J, Matta KL, Neelamegham S. 2005. Af. nity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. Biochemistry 44:9507-9519.
2. Bertuglia S, Giusti A. 2002. Blockade of P-selectin does not affect reperfusion injury in hamsters subjected to glutathione inhibition. Microvasc Res 64:56-64.
3. Colletti LM, Green M. 2001. Lung and liver injury following hepatic ischemia/reperfusion in the rat is increased by exogenous lipopolysaccharide which also increases hepatic TNF production in vivo and in vitro. Shock 16:312-319.
4. Eghtesad B, Reyes JD, Ashrafi M, Arzate J, Osorio G, Fung JJ, Mazariegos GV. 2003. Pancreatitis after liver transplantation in children: a single-center experience. Transplantation 75:190-193.
5. Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, Bach FH. 2004. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40:1333-1341.
6. Fowell AJ, Benyon RC. 2008. Can matrix metalloproteinases be targeted in hepatic ischemia/reperfusion injury? Hepatology 47: 14-16.
7. Griffon B, Cillard J, Chevanne M, Morel I, Cillard P, Sergent O. 1998. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release. Hepatology 28:1300-1308.
8. Gruessner RW, Sutherland DE, Troppmann C, Benedetti E, Hakim N, Dunn DL, Gruessner AC. 1997. The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg 185:128-144.
9. Hannah MJ, Skehel P, Erent M, Knipe L, Ogden D, Carter T. 2005. Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells. J Biol Chem 280:22827-22830.
10. Harakawa N, Shigeta A, Wato M, Merrill-Skoloff G, Furie BC, Furie B, Okazaki T, Domae N, Miyasaka M, Hirata T. 2007. P-selectin glycoprotein ligand-1 mediates L-selectin-independent leukocyte rolling in high endothelial venules of peripheral lymph nodes. Int Immunol 19:321-329.
11. Ke B, Shen XD, Lassman CR, Gao F, Busuttil RW, Kupiec-Weglinski JW. 2003. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am J Transplant 3:1076-1082.
12. Khandoga A, Enders G, Biberthaler P, Krombach F. 2002. Poly (ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 283:G553-G560.
13. Kunkel EJ, Ley K. 1996. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 79:1196-1204.
14. Lawson JA, Burns AR, Farhood A, Lynn Bajt M, Collins RG, Smith CW, Jaeschke H. 2000. Pathophysiologic importance of E-and L-selectin for neutrophil-induced liver injury during endotoxemia in mice. Hepatology 32:990-998.
15. Liu DL, Jeppsson B, Hakansson CH, Odselius R. 1996. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 131:442-447.
16. Martinez-Mier G, Toledo-Pereyra LH, McDuffie E, Warner RL, Ward PA. 2000. L-Selectin and chemokine response after liver ischemia and reperfusion. J Surg Res 93:156-162.
17. Millar TM, Phan V, Tibbles LA. 2007. ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment. Free Radic Biol Med 42:1165-1177.
18. Miras M, Carballo F, Egea J, Martinez C, Alvarez-Lopez MR, Sanchez-Bueno F, Parrilla P. 2007. Clinical evolution in the first 3 months of patients after liver transplantation in maintenance phase converted from mycophenolate mofetil to mycophenolate sodium due to gastrointestinal complications. Transplant Proc 39:2314-2317.
19. Mizunuma K, Ohdan H, Tashiro H, Fudaba Y, Ito H, Asahara T. 2003. Prevention of ischemia-reperfusion-induced hepatic micro-circulatory disruption by inhibiting stellate cell contraction using rock inhibitor. Transplantation 75:579-586.
20. Oostingh GJ, Pozgajova M, Ludwig RJ, Krahn T, Boehncke WH, Nieswandt B, Schon MP. 2007. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody-or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica 92:502-512.
21. Peralta C, Fernandez L, Panes J, Prats N, Sans M, Pique JM, Gelpi E, Rosello-Catafau J. 2001. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 33:100-113.
22. Perkins GD, Nathani N, McAuley DF, Gao F, Thickett DR. 2007. In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax 62:36-42.
23. Rizzardini M, Zappone M, Villa P, Gnocchi P, Sironi M, Diomede L, Meazza C, Monshouwer M, Cantoni L. 1998. Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta. Hepatology 27:703-710.
24. Sakamoto N, Sun Z, Brengman ML, Maemura K, Ozaki M, Bulkley GB, Klein AS. 2003. Hepatic reticuloendothelial system dysfunction after ischemia-reperfusion: role of P-selectin-mediated neutrophil accumulation. Liver Transpl 9:940-948.
25. Singh I, Zibari GB, Brown MF, Granger DN, Eppihimer M, Zizzi H, Cruz L, Meyer K, Gonzales E, McDonald JC. 1999. Role of P-selectin expression in hepatic ischemia and reperfusion injury. Clin Transplant 13:76-82.
26. Sukhotnik I, Coran AG, Greenblatt R, Brod V, Mogilner J, Shiloni E, Shaoul R, Bitterman H. 2008. Effect of 100% oxygen on E-selectin expression, recruitment of neutrophils and enterocyte apoptosis following intestinal ischemia-reperfusion in a rat. Pediatr Surg Int 24:29-35.
27. Takagi K, Matsumura S, Okuda-Ashitaka E, Okuda K, Watanabe J, Takahashi H, Iwakura Y, Ito S. 2007. Interleukin-1 is not essential for expression of inducible NOS in hepatocytes induced by lipopolysaccharide in vivo. Nitric Oxide 16:433-441.
28. Vairetti M, Ferrigno A, Rizzo V, Richelmi P, Cillo U, Imberti R. 2007. Liver damage during ischemia/reperfusion and glutathione: implications for potential organ donors. Transplant Proc 39:1768-1770.
29. Yago T, Leppanen A, Carlyon JA, Akkoyunlu M, Karmakar S, Fikrig E, Cummings RD, McEver RP. 2003. Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin. J Biol Chem 278:37987-37997.
30. Yang J, Hirata T, Croce K, Merrill-Skoloff G, Tchernychev B, Williams E, Flaumenhaft R, Furie BC, Furie B. 1999. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 190:1769-1782.